Cancer Health Center

Font Size

Childhood Acute Myeloid Leukemia/Other Myeloid Malignancies Treatment (PDQ®) - Changes to This Summary (08/22/2007)

The PDQ cancer information summaries are reviewed regularly and updated as new information becomes available. This section describes the latest changes made to this summary as of the date above.

CLASSIFICATION OF PEDIATRIC MYELOID MALIGNANCIES

Added Meshinchi et al. as reference 52.

Added Chou et al. as reference 74.

Added Thiede et al. as reference 75.

Added text stating that immunohistochemical methods can be used to accurately identify patients with nucleophosmin mutations.

Added Falini et al. as reference 77.

TREATMENT OVERVIEW FOR ACUTE MYELOID LEUKEMIA

Added text stating that the Berlin-Frankfurt-Munster 98 study confirmed a lack of benefit for the use of granulocyte colony-stimulating factor (cited Lehrnbecher et al. as reference 9).

TREATMENT OF NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA

Added Creutzig et al. as reference 13.

POSTREMISSION THERAPY FOR ACUTE MYELOID LEUKEMIA

Added text stating that indications for autologous and allogenic hematopoietic stem cell transplantation have been published (cited Oliansky et al. as reference 6).

WebMD Public Information from the National Cancer Institute

This information is produced and provided by the National Cancer Institute (NCI). The information in this topic may have changed since it was written. For the most current information, contact the National Cancer Institute via the Internet web site at http://cancer.gov or call 1-800-4-CANCER

Last Updated: August 22, 2007

This information is not intended to replace the advice of a doctor. Healthwise disclaims any liability for the decisions you make based on this information.

Some material in CancerNet™ is from copyrighted publications of the respective copyright claimants. Users of CancerNet™ are referred to the publication data appearing in the bibliographic citations, as well as to the copyright notices appearing in the original publication, all of which are hereby incorporated by reference.